Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,695.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 10.00 (0.15%)
Market Cap: £4.94b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Interim Management Statement

9 May 2013 07:00

RNS Number : 2857E
Spirax-Sarco Engineering PLC
09 May 2013
 



 

 

News Release

 

Thursday 9th May 2013

INTERIM MANAGEMENT STATEMENT

 

Spirax-Sarco Engineering plc, the world leader in the control and efficient use of steam and in peristaltic pumping, issues the following Interim Management Statement in respect of the period from 1st January 2013, ahead of its Annual General Meeting ("AGM") today at 2.00pm.

 

Trading

Global economic conditions remain broadly unchanged since we reported our 2012 results in early March and trading conditions in most of our markets have been similar to the second half of last year: we continue to see reasonably good base business but restrained customer expenditure for more costly plant improvement and energy saving projects.

 

2013 has started in line with our expectations and ahead of last year. For the four months ended 30th April 2013, sales increased by 6%, including a gain of 2% from favourable currency movements as sterling weakened. We achieved growth in all segments, led by good organic sales growth in Asia Pacific followed by Watson-Marlow. We saw modest organic sales growth in Europe, Middle East and Africa ("EMEA"), which was encouraging given the difficult economic background. In the Americas, strong progress in Latin America offset a decline in the US and Canada, where the softness towards the end of 2012 has continued into 2013.

 

At constant currency, operating profit and margin were comfortably ahead of the comparable period in 2012 reflecting the contribution from higher sales and, importantly, the further cost savings from the restructuring in Europe, net of increased costs from continued investments in market development. The performance in EMEA was markedly ahead, aided also by favourable currency movements.

 

Financial position

Our balance sheet remains very strong and the Group's net cash balance increased from £52 million at 31st December 2012 to £76 million at 30th April 2013, including £5 million due to more favourable exchange rates. If approved at the AGM, the final dividend of 37p per share in respect of 2012, totalling £29 million, will be paid on 17th May 2013 and the special dividend of 100p per share, totalling £78 million, will be paid on 3rd July 2013. There has been no material change in the financial position of the Group during the period and the principal risks and uncertainties remain as set out on pages 55 to 59 of the 2012 Annual Report.

 

Outlook

As noted in previous statements, our markets tend to broadly mirror overall economic activity and industrial production. We anticipate that low rates of industrial production growth will persist this year in most of our mature markets and that conditions in Europe will remain weak but offset by generally higher rates of industrial output in our emerging markets. Our focus is on generating our own growth through our strategic priorities of expanding our presence in emerging markets and driving benefits from the increased investment in R&D in recent years, as well as delivering the full-year cost savings of the European restructuring.

 

Our business is seasonally biased to the second half and we are anticipating a more normal first half/second half profile this year. Given the Group's robust business model and fundamental strengths, the Board remains confident that the Group will make further progress in 2013.

 

Spirax Sarco will publish its interim results on 8th August 2013.

 

 

Enquiries:

Mark E Vernon, Chief Executive

David Meredith, Director Finance

Tel: 01242 535234

 

 

 

 

About Spirax Sarco

Spirax-Sarco Engineering plc is the world leader in both steam system management and peristaltic pumping. The Company provides a broad range of fluid control products, engineered packages, site services and systems expertise for its diverse range of over 100,000 industrial and institutional customers. The Company helps its customers to optimise production capacity, reduce energy costs and emissions, improve product quality and enhance the safety of their operations. Spirax Sarco is headquartered in Cheltenham, England, has strategically located manufacturing plants around the world and employs approximately 4,700 people, of whom around 1,300 are direct sales and service engineers. Its shares have been listed on the London Stock Exchange since 1959 (symbol: SPX). Further information can be found at www.spiraxsarcoengineering.com 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBLGDUBGGBGXI
Date   Source Headline
21st Nov 20173:08 pmRNSDirector/PDMR Shareholding
21st Nov 20177:00 amRNSTrading Statement
14th Nov 201710:39 amRNSDirector/PDMR Shareholding
16th Oct 20175:35 pmRNSDirector/PDMR Shareholding
29th Sep 20173:36 pmRNSHolding(s) in Company
9th Aug 20177:00 amRNSHalf-year Report
4th Jul 20177:00 amRNSCompletion of Acquisition
23rd Jun 20179:11 amRNSTotal Voting Rights
20th Jun 20173:59 pmRNSHolding(s) in Company
12th Jun 20172:20 pmRNSDirector/PDMR Shareholding
5th Jun 20179:08 amRNSDirector/PDMR Shareholding
26th May 20177:00 amRNSAcquisition of Chromalox for US$415 million
9th May 20174:30 pmRNSResult of AGM
9th May 20177:00 amRNSTrading Statement
4th May 20174:30 pmRNSHolding(s) in Company
3rd May 20177:00 amRNSCompletion of Acquisition
26th Apr 20178:42 amRNSHolding(s) in Company
25th Apr 20179:10 amRNSHolding(s) in Company
19th Apr 20173:55 pmRNSHolding(s) in Company
18th Apr 20173:58 pmRNSHolding(s) in Company
3rd Apr 20177:30 amRNSAcquisition
24th Mar 20174:44 pmRNSTotal Voting Rights
23rd Mar 20171:45 pmRNSDirector/PDMR Shareholding
17th Mar 20174:04 pmRNSDirector/PDMR Shareholding
9th Mar 20177:00 amRNSFinal Results
30th Nov 20167:00 amRNSAcquisition
22nd Nov 20167:00 amRNSTrading Statement
17th Nov 20164:23 pmRNSDirector/PDMR Shareholding
14th Nov 20168:30 amRNSDr Krishnamurthy Rajagopal
10th Nov 201611:40 amRNSListing Application
8th Nov 201611:57 amRNSChange of Director Details
4th Nov 20164:27 pmRNSTotal Voting Rights
28th Oct 20167:00 amRNSBoard Succession Changes
17th Oct 20162:49 pmRNSAdditional Listing
14th Oct 20165:03 pmRNSDirector/PDMR Shareholding
14th Oct 20163:20 pmRNSTotal Voting Rights
14th Oct 20163:17 pmRNSBlock listing Interim Review
6th Oct 201611:48 amRNSNotification of Release Date - Trading Statement
8th Sep 201612:44 pmRNSTotal Voting Rights
18th Aug 20168:30 amRNSBoard Appointment
12th Aug 20163:51 pmRNSDirector/PDMR Shareholding
9th Aug 20167:05 amRNSSpirax Sarco acquires assets of Hiter for £3.9 m
9th Aug 20167:00 amRNS2016 Half Year Results
5th Aug 20162:56 pmRNSTotal Voting Rights
1st Jul 201611:43 amRNSTotal Voting Rights
29th Jun 20169:29 amRNSNotice of Results
21st Jun 20165:40 pmRNSDirector/PDMR Shareholding
10th Jun 20162:59 pmRNSHolding(s) in Company
2nd Jun 20164:20 pmRNSAdditional Listing
2nd Jun 20163:28 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.